David D. Aufhauser, MD

Assistant Professor

  • Division of Transplantation

(608) 265-6471

H4/752 Clinical Science Center
600 Highland Ave
Madison, WI 53792


  • MD, University of Pennsylvania, Philadelphia, PA
  • Residency, Hospital of the University of the University of Pennsylvania, Philadelphia, PA
  • Fellow, University of Wisconsin-Madison, Abdominal Transplant Surgery

Clinical Specialties

Dr. Aufhauser is certified by the American Board of Surgery (ABS) and the American Society of Transplant Surgeons (ASTS). He specializes in liver, kidney and pancreas transplantation.

Dr. Aufhauser provides a wide range of services including Pancreas Transplant, Liver Transplant, Kidney Transplant, Laparoscopic Donor Nephrectomy.

Research Interests

Dr. Aufhauser studies xenotransplantation with a focus on understanding and mitigating immune responses to xenoantigens. His long-term is to identify targets for genetic engineering and tailored immunosuppression that will facilitate clinical adaptation of xenotransplantation in humans to alleviate organ shortages.

Recent Publications

  • Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
    Concors SJ, Hernandez PT, O'Brien C, DePaolo J, Murken DR, Aufhauser DD, Wang Z, Xiong Y, Krumeich L, Ge G, Beier UH, Bhatti TR, Kozikowski AP, Avelar LAA, Kurz T, Hancock WW, Levine MH
    Transplantation 2024 Apr 30;
    [PubMed ID: 38685198]

  • Detrimental impact of early biopsy-proven rejection in liver transplantation.
    Aufhauser DD, Stalter L, Marka N, Leverson G, Al-Adra DP, Foley DP
    Clin Transplant 2024 Jan; 38(1): e15206
    [PubMed ID: 38041491]

  • Design and testing of a humanized porcine donor for xenotransplantation.
    Anand RP, Layer JV, Heja D, Hirose T, Lassiter G, Firl DJ, Paragas VB, Akkad A, Chhangawala S, Colvin RB, Ernst RJ, Esch N, Getchell K, Griffin AK, Guo X, Hall KC, Hamilton P, Kalekar LA, Kan Y, Karadagi A, Li F, Low SC, Matheson R, Nehring C, Otsuka R, Pandelakis M, Policastro RA, Pols R, Queiroz L, Rosales IA, Serkin WT, Stiede K, Tomosugi T, Xue Y, Zentner GE, Angeles-Albores D, Chris Chao J, Crabtree JN, Harken S, Hinkle N, Lemos T, Li M, Pantano L, Stevens D, Subedar OD, Tan X, Yin S, Anwar IJ, Aufhauser D, Capuano S, Kaufman DB, Knechtle SJ, Kwun J, Shanmuganayagam D, Markmann JF, Church GM, Curtis M, Kawai T, Youd ME, Qin W
    Nature 2023 Oct; 622(7982): 393-401
    [PubMed ID: 37821590]

  • A Randomized Controlled Trial of Envarsus Versus Immediate Release Tacrolimus in Kidney Transplant Recipients With Delayed Graft Function.
    Parajuli S, Muth B, Bloom M, Ptak L, Aufhauser D, Thiessen C, Al-Adra D, Mezrich J, Neidlinger N, Odorico J, Wang JG, Foley D, Kaufman D, Mandelbrot DA
    Transplant Proc 2023 Sep; 55(7): 1568-1574
    [PubMed ID: 37394382]

  • Higher Fasting Pretransplant C-peptide Levels in Type 2 Diabetics Undergoing Simultaneous Pancreas-kidney Transplantation Are Associated With Posttransplant Pancreatic Graft Dysfunction.
    Parajuli S, Mandelbrot D, Aufhauser D, Kaufman D, Odorico J
    Transplantation 2023 Apr 01; 107(4): e109-e121
    [PubMed ID: 36706060]

All Publications on PubMed